| Symbol |
Name |
|
A2M
|
alpha-2-macroglobulin
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACTA1
|
actin, alpha 1, skeletal muscle
|
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
ACTN4
|
actinin, alpha 4
|
|
ACVR1
|
activin A receptor, type I
|
|
ACYP2
|
acylphosphatase 2, muscle type
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM8
|
ADAM metallopeptidase domain 8
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAMTS19
|
ADAM metallopeptidase with thrombospondin type 1 motif, 19
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AFP
|
alpha-fetoprotein
|
|
AGGF1
|
angiogenic factor with G patch and FHA domains 1
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALB
|
albumin
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALDH1A2
|
aldehyde dehydrogenase 1 family, member A2
|
|
ALDH1B1
|
aldehyde dehydrogenase 1 family, member B1
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
ANKH
|
ANKH inorganic pyrophosphate transport regulator
|
|
ANKRD6
|
ankyrin repeat domain 6
|
|
ANXA3
|
annexin A3
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA2
|
apolipoprotein A-II
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOC2
|
apolipoprotein C-II
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
ARAP1
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1
|
|
AREG
|
amphiregulin
|
|
ARF1
|
ADP-ribosylation factor 1
|
|
ARF5
|
ADP-ribosylation factor 5
|
|
ARHGEF4
|
Rho guanine nucleotide exchange factor (GEF) 4
|
|
ARHGEF6
|
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ASAH1
|
N-acylsphingosine amidohydrolase (acid ceramidase) 1
|
|
ASPA
|
aspartoacylase
|
|
ASPM
|
asp (abnormal spindle) homolog, microcephaly associated (Drosophila)
|
|
ATL1
|
atlastin GTPase 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATOH7
|
atonal homolog 7 (Drosophila)
|
|
ATP13A2
|
ATPase type 13A2
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
|
ATXN1
|
ataxin 1
|
|
ATXN2
|
ataxin 2
|
|
ATXN3
|
ataxin 3
|
|
ATXN8OS
|
ATXN8 opposite strand (non-protein coding)
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AVP
|
arginine vasopressin
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BSCL2
|
Berardinelli-Seip congenital lipodystrophy 2 (seipin)
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
C11ORF30
|
chromosome 11 open reading frame 30
|
|
C3
|
complement component 3
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CA1
|
carbonic anhydrase I
|
|
CA2
|
carbonic anhydrase II
|
|
CA9
|
carbonic anhydrase IX
|
|
CADM2
|
cell adhesion molecule 2
|
|
CARD10
|
caspase recruitment domain family, member 10
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCK
|
cholecystokinin
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCNA1
|
cyclin A1
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCNL1
|
cyclin L1
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD1B
|
CD1b molecule
|
|
CD24
|
CD24 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDH17
|
cadherin 17, LI cadherin (liver-intestine)
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
CEP152
|
centrosomal protein 152kDa
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFH
|
complement factor H
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGGBP1
|
CGG triplet repeat binding protein 1
|
|
CHD8
|
chromodomain helicase DNA binding protein 8
|
|
CHGA
|
chromogranin A
|
|
CHRM2
|
cholinergic receptor, muscarinic 2
|
|
CKAP2
|
cytoskeleton associated protein 2
|
|
CKB
|
creatine kinase, brain
|
|
CKM
|
creatine kinase, muscle
|
|
CKS1B
|
CDC28 protein kinase regulatory subunit 1B
|
|
CLASP2
|
cytoplasmic linker associated protein 2
|
|
CLDN2
|
claudin 2
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COL4A6
|
collagen, type IV, alpha 6
|
|
COMT
|
catechol-O-methyltransferase
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CREM
|
cAMP responsive element modulator
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAA
|
crystallin, alpha A
|
|
CST3
|
cystatin C
|
|
CSTP1
|
cystatin pseudogene 1
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTSD
|
cathepsin D
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP21A1P
|
cytochrome P450, family 21, subfamily A, polypeptide 1 pseudogene
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP4F2
|
cytochrome P450, family 4, subfamily F, polypeptide 2
|
|
CYP7A1
|
cytochrome P450, family 7, subfamily A, polypeptide 1
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DACH1
|
dachshund family transcription factor 1
|
|
DCLRE1A
|
DNA cross-link repair 1A
|
|
DEF6
|
differentially expressed in FDCP 6 homolog (mouse)
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DKC1
|
dyskeratosis congenita 1, dyskerin
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DMD
|
dystrophin
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
|
DNM2
|
dynamin 2
|
|
DOK7
|
docking protein 7
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPP6
|
dipeptidyl-peptidase 6
|
|
DRD3
|
dopamine receptor D3
|
|
DRD4
|
dopamine receptor D4
|
|
DSTN
|
destrin (actin depolymerizing factor)
|
|
DUSP12
|
dual specificity phosphatase 12
|
|
EDN1
|
endothelin 1
|
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EIF6
|
eukaryotic translation initiation factor 6
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA1
|
EPH receptor A1
|
|
EPHB4
|
EPH receptor B4
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETV4
|
ets variant 4
|
|
EZR
|
ezrin
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FAF2
|
Fas associated factor family member 2
|
|
FBLN1
|
fibulin 1
|
|
FBN2
|
fibrillin 2
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCHO2
|
FCH domain only 2
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FGA
|
fibrinogen alpha chain
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FHIT
|
fragile histidine triad
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FKBP8
|
FK506 binding protein 8, 38kDa
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FST
|
follistatin
|
|
FTO
|
fat mass and obesity associated
|
|
FXN
|
frataxin
|
|
FXYD5
|
FXYD domain containing ion transport regulator 5
|
|
GCG
|
glucagon
|
|
GDF5
|
growth differentiation factor 5
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GHR
|
growth hormone receptor
|
|
GHRHR
|
growth hormone releasing hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GIP
|
gastric inhibitory polypeptide
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLYAT
|
glycine-N-acyltransferase
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GPC3
|
glypican 3
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPHN
|
gephyrin
|
|
GPR143
|
G protein-coupled receptor 143
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
|
GRB10
|
growth factor receptor-bound protein 10
|
|
GRIK2
|
glutamate receptor, ionotropic, kainate 2
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
H2AFX
|
H2A histone family, member X
|
|
HCN2
|
hyperpolarization activated cyclic nucleotide gated potassium channel 2
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMOX1
|
heme oxygenase 1
|
|
HOXA1
|
homeobox A1
|
|
HOXD13
|
homeobox D13
|
|
HP
|
haptoglobin
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSF1
|
heat shock transcription factor 1
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTT
|
huntingtin
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFALS
|
insulin-like growth factor binding protein, acid labile subunit
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP6
|
insulin-like growth factor binding protein 6
|
|
IGFL1
|
IGF-like family member 1
|
|
IL2
|
interleukin 2
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
INHA
|
inhibin, alpha
|
|
INHBA
|
inhibin, beta A
|
|
INHBB
|
inhibin, beta B
|
|
INS
|
insulin
|
|
INSIG2
|
insulin induced gene 2
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITIH5
|
inter-alpha-trypsin inhibitor heavy chain family, member 5
|
|
ITLN1
|
intelectin 1 (galactofuranose binding)
|
|
JAK2
|
Janus kinase 2
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNK3
|
potassium channel, two pore domain subfamily K, member 3
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KDR
|
kinase insert domain receptor
|
|
KIF4A
|
kinesin family member 4A
|
|
KIR2DL3
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
|
|
KIR2DL4
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
|
|
KIR2DS1
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF17
|
Kruppel-like factor 17
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLK14
|
kallikrein-related peptidase 14
|
|
KLK4
|
kallikrein-related peptidase 4
|
|
KPNA3
|
karyopherin alpha 3 (importin alpha 4)
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT17
|
keratin 17, type I
|
|
KRT19
|
keratin 19, type I
|
|
KSR1
|
kinase suppressor of ras 1
|
|
LAMA3
|
laminin, alpha 3
|
|
LAMB1
|
laminin, beta 1
|
|
LATS2
|
large tumor suppressor kinase 2
|
|
LCN1
|
lipocalin 1
|
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin)
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEP
|
leptin
|
|
LEPQTL1
|
Leptin, serum levels of
|
|
LEPR
|
leptin receptor
|
|
LGALS13
|
lectin, galactoside-binding, soluble, 13
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LINC00312
|
long intergenic non-protein coding RNA 312
|
|
LIPC
|
lipase, hepatic
|
|
LMNA
|
lamin A/C
|
|
LMNB1
|
lamin B1
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPL
|
lipoprotein lipase
|
|
LRP8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTBP4
|
latent transforming growth factor beta binding protein 4
|
|
LY96
|
lymphocyte antigen 96
|
|
LYRM1
|
LYR motif containing 1
|
|
LYST
|
lysosomal trafficking regulator
|
|
MADD
|
MAP-kinase activating death domain
|
|
MAGEC2
|
melanoma antigen family C2
|
|
MAP1LC3A
|
microtubule-associated protein 1 light chain 3 alpha
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP4K4
|
mitogen-activated protein kinase kinase kinase kinase 4
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBTPS1
|
membrane-bound transcription factor peptidase, site 1
|
|
MBTPS2
|
membrane-bound transcription factor peptidase, site 2
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MCM5
|
minichromosome maintenance complex component 5
|
|
MCPH1
|
microcephalin 1
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFN2
|
mitofusin 2
|
|
MIR126
|
microRNA 126
|
|
MIR134
|
microRNA 134
|
|
MIR143
|
microRNA 143
|
|
MIR181C
|
microRNA 181c
|
|
MIR195
|
microRNA 195
|
|
MIR199A1
|
microRNA 199a-1
|
|
MIR380
|
microRNA 380
|
|
MIR429
|
microRNA 429
|
|
MIR9-1
|
microRNA 9-1
|
|
MIR9-2
|
microRNA 9-2
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MSH2
|
mutS homolog 2
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MSTN
|
myostatin
|
|
MT1F
|
metallothionein 1F
|
|
MT2A
|
metallothionein 2A
|
|
MTA2
|
metastasis associated 1 family, member 2
|
|
MTERF1
|
mitochondrial transcription termination factor 1
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTM1
|
myotubularin 1
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming
|
|
MUSK
|
muscle, skeletal, receptor tyrosine kinase
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NAA10
|
N(alpha)-acetyltransferase 10, NatA catalytic subunit
|
|
ND1
|
|
|
NEDD9
|
neural precursor cell expressed, developmentally down-regulated 9
|
|
NF1
|
neurofibromin 1
|
|
NFIB
|
nuclear factor I/B
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPPB
|
natriuretic peptide B
|
|
NPY
|
neuropeptide Y
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NRBF2
|
nuclear receptor binding factor 2
|
|
NRG1
|
neuregulin 1
|
|
NTN1
|
netrin 1
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NUS1
|
nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae)
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
OPN4
|
opsin 4
|
|
P2RX4
|
purinergic receptor P2X, ligand gated ion channel, 4
|
|
PABPN1
|
poly(A) binding protein, nuclear 1
|
|
PAGR1
|
PAXIP1 associated glutamate-rich protein 1
|
|
PAH
|
phenylalanine hydroxylase
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PAX9
|
paired box 9
|
|
PCDH10
|
protocadherin 10
|
|
PCTP
|
phosphatidylcholine transfer protein
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PHF8
|
PHD finger protein 8
|
|
PI4KA
|
phosphatidylinositol 4-kinase, catalytic, alpha
|
|
PKP1
|
plakophilin 1
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCL1
|
phospholipase C-like 1
|
|
PLIN1
|
perilipin 1
|
|
PLIN2
|
perilipin 2
|
|
PLN
|
phospholamban
|
|
PLTP
|
phospholipid transfer protein
|
|
PMEL
|
premelanosome protein
|
|
PNPLA2
|
patatin-like phospholipase domain containing 2
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
POLA1
|
polymerase (DNA directed), alpha 1, catalytic subunit
|
|
PON1
|
paraoxonase 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPA1
|
pyrophosphatase (inorganic) 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPFIA1
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1
|
|
PPP1R9B
|
protein phosphatase 1, regulatory subunit 9B
|
|
PRC1
|
protein regulator of cytokinesis 1
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRKCI
|
protein kinase C, iota
|
|
PRL
|
prolactin
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROM1
|
prominin 1
|
|
PROP1
|
PROP paired-like homeobox 1
|
|
PRR16
|
proline rich 16
|
|
PRSS56
|
protease, serine, 56
|
|
PSMD9
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PYY
|
peptide YY
|
|
RAB6A
|
RAB6A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD9A
|
RAD9 homolog A (S. pombe)
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RB1
|
retinoblastoma 1
|
|
RB1CC1
|
RB1-inducible coiled-coil 1
|
|
RBM5
|
RNA binding motif protein 5
|
|
REG4
|
regenerating islet-derived family, member 4
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REN
|
renin
|
|
REPIN1
|
replication initiator 1
|
|
RET
|
ret proto-oncogene
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
S100A6
|
S100 calcium binding protein A6
|
|
S100B
|
S100 calcium binding protein B
|
|
S100P
|
S100 calcium binding protein P
|
|
SAMD4A
|
sterile alpha motif domain containing 4A
|
|
SBDS
|
Shwachman-Bodian-Diamond syndrome
|
|
SCGB3A2
|
secretoglobin, family 3A, member 2
|
|
SCN8A
|
sodium channel, voltage gated, type VIII alpha subunit
|
|
SCT
|
secretin
|
|
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
|
|
SEMA5B
|
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
|
|
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5
|
|
SERPINB3
|
serpin peptidase inhibitor, clade B (ovalbumin), member 3
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINI1
|
serpin peptidase inhibitor, clade I (neuroserpin), member 1
|
|
SF3B2
|
splicing factor 3b, subunit 2, 145kDa
|
|
SF3B4
|
splicing factor 3b, subunit 4, 49kDa
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SGCE
|
sarcoglycan, epsilon
|
|
SH3PXD2A
|
SH3 and PX domains 2A
|
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHH
|
sonic hedgehog
|
|
SHOX
|
short stature homeobox
|
|
SIAH1
|
siah E3 ubiquitin protein ligase 1
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC12A2
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 2
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SMAD7
|
SMAD family member 7
|
|
SMC4
|
structural maintenance of chromosomes 4
|
|
SMUG1
|
single-strand-selective monofunctional uracil-DNA glycosylase 1
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNCB
|
synuclein, beta
|
|
SOCS2
|
suppressor of cytokine signaling 2
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing
|
|
SOST
|
sclerostin
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
ST8SIA1
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1
|
|
STARD10
|
StAR-related lipid transfer (START) domain containing 10
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STC1
|
stanniocalcin 1
|
|
STC2
|
stanniocalcin 2
|
|
STIL
|
SCL/TAL1 interrupting locus
|
|
TARDBP
|
TAR DNA binding protein
|
|
TERC
|
telomerase RNA component
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFR2
|
transferrin receptor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
THPO
|
thrombopoietin
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TJP1
|
tight junction protein 1
|
|
TLR10
|
toll-like receptor 10
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT1
|
troponin T type 1 (skeletal, slow)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TNXB
|
tenascin XB
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP53AIP1
|
tumor protein p53 regulated apoptosis inducing protein 1
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPM2
|
tropomyosin 2 (beta)
|
|
TPM3
|
tropomyosin 3
|
|
TPX2
|
TPX2, microtubule-associated
|
|
TRA
|
T cell receptor alpha locus
|
|
TRB
|
T cell receptor beta locus
|
|
TRIM63
|
tripartite motif containing 63, E3 ubiquitin protein ligase
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TXN
|
thioredoxin
|
|
UBE2C
|
ubiquitin-conjugating enzyme E2C
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VRK2
|
vaccinia related kinase 2
|
|
VWF
|
von Willebrand factor
|
|
WFDC12
|
WAP four-disulfide core domain 12
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
|
YAP1
|
Yes-associated protein 1
|
|
ZAK
|
sterile alpha motif and leucine zipper containing kinase AZK
|
|
ZBTB33
|
zinc finger and BTB domain containing 33
|
|
ZDHHC8
|
zinc finger, DHHC-type containing 8
|
|
ZNF174
|
zinc finger protein 174
|
|
ZNF335
|
zinc finger protein 335
|
